Clarity
The future of ovarian cancer screening
A simple, routine, affordable annual blood test designed to detect ovarian cancer early before it's too late. We're creating the mammogram of ovarian cancer.
The Problem We're Solving
Ovarian cancer is one of the deadliest cancers for women, yet early detection remains a critical challenge.
Silent Killer
Often called the "silent killer," ovarian cancer typically shows no symptoms until advanced stages, when treatment is far less effective.
Invasive Diagnosis
Currently, definitive diagnosis requires invasive biopsy surgery a procedure that's risky, expensive, and not suitable for routine screening.
No Routine Screening
Unlike breast cancer with mammograms or cervical cancer with pap smears, there's no simple, affordable screening test for ovarian cancer.
Early Detection Changes Everything
When ovarian cancer is detected in its earliest stages, the five-year survival rate exceeds 90%. Our mission is to make early detection accessible to every woman through a simple annual blood test.
Our Solution: A Simple Blood Test
Clarity is developing a breakthrough diagnostic that makes ovarian cancer screening as simple and routine as checking your cholesterol.
Simple Blood Draw
No invasive procedures. Just a routine blood sample at your annual checkup.
Annual Screening
Designed for yearly testing, catching cancer at its earliest, most treatable stages.
Accessible & Affordable
We're committed to making this test affordable and accessible to women everywhere.
Early Detection
Detecting cancer before symptoms appear, when treatment is most successful.
Becoming the Standard of Care
Meet Our Team
Driven by science, motivated by impact, committed to saving lives.
Alexandra Collins
CoFounder & Chief Scientific Officer
Alexandra brings dual expertise in AI and operational execution essential for scaling computational biology diagnostics. With degrees in Computer Science (AI) and Management Science & Engineering from Stanford, where she conducted AI algorithm research in the Human Centered AI and Language Data and Reasoning Labs, she bridges technical architecture and business strategy. Her proven ability to execute at scale includes co founding an international environmental non profit that successfully stopped carcinogenic ethylene oxide pollution and secured new legislation, demonstrating regulatory navigation and stakeholder mobilization skills critical for healthcare commercialization. As President of Stanford Women in Computer Science (1,400+ members), she developed the leadership capabilities needed to build and scale high performing teams.